These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15317808)

  • 21. Identification of carboxyl residues in pepstatin-insensitive carboxyl proteinase from Pseudomonas sp. 101 that participate in catalysis and substrate binding.
    Ito M; Narutaki S; Uchida K; Oda K
    J Biochem; 1999 Jan; 125(1):210-6. PubMed ID: 9880819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Slow-tight binding inhibition of pepsin by an aspartic protease inhibitor from Streptomyces sp. MBR04.
    Menon V; Rao M
    Int J Biol Macromol; 2012; 51(1-2):165-74. PubMed ID: 22522047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimalarial effects of human immunodeficiency virus type 1 protease inhibitors differ from those of the aspartic protease inhibitor pepstatin.
    Parikh S; Liu J; Sijwali P; Gut J; Goldberg DE; Rosenthal PJ
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2207-9. PubMed ID: 16723585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspartic protease-pepstatin A interactions: Structural insights on the thermal inactivation mechanism.
    Purushothaman K; Bhat SK; Siddappa S; Singh SA; Subbaiah R; Marathe GK; Rao G Appu Rao A
    Biochimie; 2021 Oct; 189():26-39. PubMed ID: 34116131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calculating proton uptake/release and binding free energy taking into account ionization and conformation changes induced by protein-inhibitor association: application to plasmepsin, cathepsin D and endothiapepsin-pepstatin complexes.
    Alexov E
    Proteins; 2004 Aug; 56(3):572-84. PubMed ID: 15229889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential inhibition of GH family 11 endo-xylanase by rice xylanase inhibitor and verification by a modified yeast two-hybrid system.
    Liu M; Wu X; Huo W; Li J; Weng X; Liu J; Fang Z
    Int J Biol Macromol; 2019 Jul; 132():514-523. PubMed ID: 30951774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pepstatin A, an aspartic proteinase inhibitor, suppresses RANKL-induced osteoclast differentiation.
    Yoshida H; Okamoto K; Iwamoto T; Sakai E; Kanaoka K; Hu JP; Shibata M; Hotokezaka H; Nishishita K; Mizuno A; Kato Y
    J Biochem; 2006 Mar; 139(3):583-90. PubMed ID: 16567424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The kinetic factors that determine the affinity and selectivity for slow binding inhibition of human prostaglandin H synthase 1 and 2 by indomethacin and flurbiprofen.
    Callan OH; So OY; Swinney DC
    J Biol Chem; 1996 Feb; 271(7):3548-54. PubMed ID: 8631960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification and characterization of a hemoglobin degrading aspartic protease from the malarial parasite Plasmodium vivax.
    Sharma A; Eapen A; Subbarao SK
    J Biochem; 2005 Jul; 138(1):71-8. PubMed ID: 16046450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. X-ray-crystallographic studies of complexes of pepstatin A and a statine-containing human renin inhibitor with endothiapepsin.
    Bailey D; Cooper JB; Veerapandian B; Blundell TL; Atrash B; Jones DM; Szelke M
    Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):363-71. PubMed ID: 8424781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors.
    Cutfield SM; Dodson EJ; Anderson BF; Moody PC; Marshall CJ; Sullivan PA; Cutfield JF
    Structure; 1995 Nov; 3(11):1261-71. PubMed ID: 8591036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases.
    Richards AD; Roberts R; Dunn BM; Graves MC; Kay J
    FEBS Lett; 1989 Apr; 247(1):113-7. PubMed ID: 2651157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parasite killing in Plasmodium vivax malaria by nitric oxide: implication of aspartic protease inhibition.
    Sharma A; Eapen A; Subbarao SK
    J Biochem; 2004 Sep; 136(3):329-34. PubMed ID: 15598889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition and binding kinetics of the hepatitis C virus NS3 protease inhibitor ITMN-191 reveals tight binding and slow dissociative behavior.
    Rajagopalan R; Misialek S; Stevens SK; Myszka DG; Brandhuber BJ; Ballard JA; Andrews SW; Seiwert SD; Kossen K
    Biochemistry; 2009 Mar; 48(11):2559-68. PubMed ID: 19209850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of XMRV and HIV-1 proteases by pepstatin A and acetyl-pepstatin.
    Matúz K; Mótyán J; Li M; Wlodawer A; Tőzsér J
    FEBS J; 2012 Sep; 279(17):3276-86. PubMed ID: 22804908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pepstatin inhibition mechanism.
    Marciniszyn J; Hartsuck JA; Tang J
    Adv Exp Med Biol; 1977; 95():199-210. PubMed ID: 339690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ab initio molecular dynamics-based assignment of the protonation state of pepstatin A/HIV-1 protease cleavage site.
    Piana S; Sebastiani D; Carloni P; Parrinello M
    J Am Chem Soc; 2001 Sep; 123(36):8730-7. PubMed ID: 11535077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel cell penetrating aspartic protease inhibitor blocks processing and presentation of tetanus toxoid more efficiently than pepstatin A.
    Zaidi N; Burster T; Sommandas V; Herrmann T; Boehm BO; Driessen C; Voelter W; Kalbacher H
    Biochem Biophys Res Commun; 2007 Dec; 364(2):243-9. PubMed ID: 17937927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substrate specificities of pepstatin-insensitive carboxyl proteinases from gram-negative bacteria.
    Ito M; Dunn BM; Oda K
    J Biochem; 1996 Oct; 120(4):845-50. PubMed ID: 8947851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linear non-competitive inhibition of solubilized human gamma-secretase by pepstatin A methylester, L685458, sulfonamides, and benzodiazepines.
    Tian G; Sobotka-Briner CD; Zysk J; Liu X; Birr C; Sylvester MA; Edwards PD; Scott CD; Greenberg BD
    J Biol Chem; 2002 Aug; 277(35):31499-505. PubMed ID: 12072428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.